Firms Marketing In Japan Should Plan For License Renewals Under New Law
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers that obtained a Japanese marketing license ("kyoka") in Japan before the revised Pharmaceutical Affairs Law (PAL) went into effect last April should allow time to come into compliance before the license expires, according to Steve McRoberts, global principal engineer at Underwriters Laboratories